Microdyn-Nadir and Ovivo Turn Partners to Capture MBR Markets
Published on by Water Network Research, Official research team of The Water Network in Business
Microdyn-Nadir has signed a multi-year agreement with Canadian water treatment firm Ovivo for servicing the membrane bioreactor (MBR) market in the US
Ovivo Inc. ("Ovivo") signed an unprecedented, multi-year agreement, with Microdyn-Nadir (''Microdyn'') to service the U.S. membrane bioreactor (MBR) market. The agreement secures access to BIO-CEL® membrane technology and includes a collaborative venture to build private-label membrane equipment (OVTM). Combining Ovivo system integration expertise with the Microdyn membrane manufacturing knowledge is expected to rapidly drive innovation, increase quality, reduce costs and improve delivery times. In one of the fastest growing segments of the wastewater treatment industry, Ovivo will now be positioned as the clear leader in the U.S. market.
MBR systems are considered the best available treatment (B.A.T.) or the most advanced technology in the wastewater industry. In fact, Ovivo® MBR systems are routinely designed to produce the highest quality reuse effluent and to meet the most stringent nutrient limits. It has also become the technology of choice for upgrading, expanding and retrofitting outdated or failing facilities. For these reasons and others, the demand for MBR has steadily increased over the last 10 years. However, the rate of growth has been limited by misconceptions about cost of ownership and membrane life. The new Ovivo-Microdyn partnership will address both of these issues by offering BulletProofTM OVTM membrane units equipped with BIO-CEL® technology and integrated into Ovivo® MBR systems.
As part of the new partnership, Microdyn has agreed to build a second production line for BIO-CEL® membranes. The new line will most likely be located in Austin, Texas, in cooperation with Ovivo U.S. operations, with production set to begin in January 2017. "We are delighted to extend our partnership with Microdyn and to collaborate closely with them in providing highly-effective MBR systems to our clients," said Marc Barbeau, Ovivo's President and Chief Executive Officer. "Their new production line near our U.S. operations should provide us with more innovation flexibility and agility for our MBR solutions, in a constantly evolving environment," added Mr. Barbeau.
Ovivo will benefit from the new line and so will its partner, Microdyn. "Local market presence is key to being a meaningful player inNorth America", says Walter Lamparter, CEO at Microdyn. "With our second BIO-CEL® line, we will be able to minimize freight costs and realize shorter delivery times. Together with our local U.S. partner Ovivo, we offer decades of experience in MBR technology," added Mr. Lamparter.
Source: PR News Wire
Read More Related Content On This Topic - Click Here
Media
Taxonomy
- Membrane Bioreactor Systems
- Finance and Markets
- Governance & Planning